FDA Clears New Blood Glucose Reference Analyzer from Nova Biomedical
The U.S. Food and Drug Administration has cleared Nova Biomedical’s new blood glucose reference analyzer, Nova Primary.
The U.S. Food and Drug Administration has cleared Nova Biomedical’s new blood glucose reference analyzer, Nova Primary.
The Tech Guide from the May 2021 issue of Clinical Lab Products includes clinical chemistry and integrated analyzers from Beckman Coulter, Carolina Liquid Chemistries, Diatron, Fujirebio, Ortho Clinical Diagnostics, Siemens, Thermo Fisher Scientific, and more.
Nova Primary fills the need for a new glucose reference analyzer to replace the YSI Stat Plus 2300 Glucose and L-Lactate analyzer, which will no longer be supported beginning in July 2021.
The Ark fentanyl assay will provide laboratories with a greater window to screen for fentanyl to more effectively triage patients who have been exposed to this opioid.
The kit combines the Steripath Gen2 initial specimen diversion device with additional supplies required for the collection of blood culture samples that are virtually free of contamination.
Already available in countries requiring the CE mark, the RapidPoint 500e blood gas analyzer is now available for critical care testing in the United States.
The current generation of instruments for in vitro diagnostics is helping to support clinical labs through a strong emphasis on automation.
The peer group program enables laboratories to troubleshoot issues quickly by providing instant and monthly reports to evaluate internal and external performance in real-time.